During the last several years, the pharmacist has acted as a primary-care provider for patients with selected chronic illnesses at an urban county health department. The pharmacist's responsibilities include examining patients, ordering laboratory tests and X-rays, and adjusting or prescribing medication.
In order to comply with health department regulations requiring the use of protocols by non-physician practitioners, and to better define the pharmacist's role, pharmacy protocols for the treatment of essential hypertension and type II diabetes mellitus have been developed. The protocols provide specific guidelines for the pharmacist involved in primary patient care. In addition, they describe a procedure for the selection and referral of patients.
These protocols can serve as a sound foundation by which other pharmacists involved with primary patient care treat essential hypertension and type II diabetes mellitus. They can easily be modified to suit a pharmacist's particular needs and situation.
AndersonPO, TaryleDA. Pharmacist management of patients using formalized standards of care.Am J Hosp Pharm1974; 31: 254–7.
2.
EricksonSH. Primary care by a pharmacist in an outpatient clinic.Am J Hosp Pharm1977; 34: 1086–90.
3.
GriffinJD. The pharmacist as a primary provider of maintenance health care.Hosp Pharm1974; 9: 84–101.
4.
MatiellaA, NeaseKO, CaplanMF. Portrait of a pharmacy primary care program.J Am Pharm Assoc1976; NS16: 455–9.
5.
MatteiTJ, BalmerJA, CorbinLA, DuffyMG. Hypertension: a role model for pharmacy involvement.Am J Hosp Pharm1973; 30: 683–6.
6.
ReindersTP, RushDR, BaumgartnerRP, GrahamAW. Pharmacist's role in management of hypertensive patients in an ambulatory care clinic.Am J Hosp Pharm1975; 32: 590–4.
7.
TiggelaarJM, LoveDW, PahlRC. Establishing a pharmacy clinic in a city-county health department.Drug Intell Clin Pharm1984; 18: 415–6.
8.
The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.Arch Intern Med1984; 144: 1045–57.
9.
HallWD, WollamGL, TuttleEP. Diagnostic evaluation of the patient with hypertension. In: HurstJW, ed. The heart.New York: McGraw-Hill, 1986: 1048–70.
10.
DuncanJJ, FarrJE, UptonSJ, HaganRD, OglesbyME, BlairSN. The effects of aerobic exercise on plasma catecholamines and blood pressure in patients with mild essential hypertension.JAMA1985; 254: 2609–13.
11.
KaplanNM. Non-drug treatment of hypertension.Ann Intern Med1985; 102: 359–73.
12.
KaplanNM. Initial treatment of adult patients with essential hypertension: II. Alternating monotherapy is the preferred treatment.Pharmacotherapy1985; 5: 195–200.
13.
LangfordHG, BlaufoxMD, ObermanA. Dietary therapy slows the return of hypertension after stopping prolonged medication.JAMA1985; 253: 657–64.
14.
StamlerJ, FarinaroE, MojonnierLM, HallY, MossD, StamlerR. Prevention and control of hypertension by nutritional-hygienic means.JAMA1980; 243: 1819–23.
15.
TruswellAS. Diet and hypertension.Br Med J1985; 291: 125–7.
16.
WeinsierRL, NorrisD. Recent developments in the etiology and treatment of hypertension: dietary calcium, fat, and magnesium.Am J Clin Nutr1985; 42: 1331–8.
17.
MarzukPM. Biofeedback for hypertension.Ann Intern Med1985; 102: 709–15.
18.
MoserM. Initial treatment of adult patients with essential hypertension: I. Why conventional stepped-care therapy of hypertension is still indicated.Pharmacotherapy1985; 5: 189–95.
19.
Drugs for hypertension.Med Lett Drugs Ther1984; 140: 522–4.
20.
Hunter Hypertension Research Group.Changes in serum lipid levels during antihypertensive therapy.Med J Aust1984; 140: 522–4.
21.
GutschiLM, RybakMJ. Antihypertensive agents and hyperlipidemia.Clin Pharm1984; 3: 587–8.
22.
RiddioughMA. Preventing, detecting and managing adverse reactions of antihypertensive agents in the ambulant patient with essential hypertension.Am J Hosp Pharm1977; 34: 465–79.
23.
FinnertyFA. Step-down therapy for hypertension.Postgrad Med1985; 77(7): 78–85.
24.
HollifieldJW. Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension.Am J Med1984; 77(5A): 28–32.
25.
KaplanNM, CarnegieA, RaskinP, HellerJA, SimmonsM. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia.N Engl J Med1985; 312: 746–9.
26.
AmesRP, HillP. Improvement of glucose tolerance and lowering of glycohemoglobin and serum lipid concentrations after discontinuation of antihypertensive drug therapy.Circulation1982; 65: 899–904.
RobertsonL, FlindersC, BronwenG. Laurel's kitchen: a handbook for vegetarian cookery and nutrition.New York: Bantam Books, 1976: 498–9.
29.
RifkinH, ed. The physician's guide to type II diabetes (NIDDM).Diagnosis and treatment.New York: American Diabetes Association, 1984: 25–52.
30.
El-Beheri BurgessBR. Rationale for changes in the dietary management of diabetes.J Am Diet Assoc1982; 81: 258–60.
31.
NutallFQ, BrunzellJD. Principles of nutrition and dietary recommendations for individuals with diabetes mellitus: 1979.Diabetes1979; 28: 1027–30.
32.
SkylerJS, BeattyCM, GoldbergRB. Managing diabetes: an updated look at diet.Geriatrics1984; 39(7): 57–68.
33.
University Group Diabetes Program.A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes II. Mortality results.Diabetes1970; 19: 789–830.
34.
SeltzerHS. A summary of criticisms of the findings and conclusions of the university group diabetes program (UGDP).Diabetes1972: 21: 976–9.
35.
Proutte, KnatterudGL, MeinertCL, KlimtCR. The UGDP controversy: clinical trials versus clinical impressions.Diabetes1972; 21: 1035–40.
36.
KiloC, MillerJP, WilliamsonJR. The crux of the UGDP: spurious results and biologically inappropriate data analysis.Diabetologia1980; 18: 179–85.
37.
Koda-KimbleMA, RotblattMD. Diabetes mellitus. In: KatcherBS, YoungLY, Koda-KimbleMA, eds. Applied therapeutics.The clinical use of drugs. San Francisco: Applied therapeutics, 1983: 1335–414.
38.
GerichJE. Sulfonylureas in the treatment of diabetes mellitus—1985.Mayo Clin Proc1985; 60: 439–43.
39.
AsmalAC, MarbleA. Oral hypoglycemic agents: an update.Drugs1984; 28: 62–78.
